Pancreatic Cancer Research

ResearcherHammersmith HospitalNo recent work listed

Justin Stebbing

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1117-6947; OpenAlex author ID A5079409805. Sources: OpenAlex.

Their work

Papers
17 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
35
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: 3 papers · 2014: 3 papers · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 3 papers · 2019: 1 paper

Papers 17

  1. Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. First author DOI 10.1038/s41467-019-11752-2↗
  2. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. First author DOI 10.1038/s41467-018-03962-x↗
  3. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden. Co-author DOI 10.18632/oncotarget.24873↗
  4. Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma. Co-author DOI 10.21037/jgo.2018.01.14↗
  5. Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer. First author DOI 10.1038/bjc.2016.271↗
  6. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis. Last author DOI 10.1016/j.ejca.2015.04.006↗
  7. Usefulness of Measuring microRNAs in Bile and Plasma for Pancreatic Ductal Adenocarcinoma Diagnosis. Co-author DOI 10.1038/ajg.2015.77↗
  8. Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. Co-author DOI 10.1001/jamasurg.2013.3643↗
  9. Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. Co-author DOI 10.1371/journal.pone.0090948↗
  10. A microRNA meta-signature for pancreatic ductal adenocarcinoma. Co-author DOI 10.1586/14737159.2014.893192↗
  11. Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker? Co-author DOI 10.1586/14737159.2013.845091↗
  12. Towards a clinical use of miRNAs in pancreatic cancer biopsies. Co-author DOI 10.1586/erm.12.136↗
  13. Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer. Co-author DOI 10.1586/erm.13.31↗
  14. The role of miR-10b in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.surg.2012.03.021↗
  15. Loss of miR-126 is crucial to pancreatic cancer progression. Co-author DOI 10.1586/era.12.67↗
  16. Can pharmacogenomics guide effective anticancer therapy in pancreatic ductal adenocarcinoma? Last author DOI 10.2217/pgs.12.73↗
  17. microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1586/era.11.184↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Adam Enver Frampton · 14 shared papers, 2011–2019 · strength 0.68
  2. Jonathan Krell · 13 shared papers, 2011–2019 · strength 0.62
  3. Long R. Jiao · 12 shared papers, 2011–2019 · strength 0.58
  4. Leandro Castellano · 12 shared papers, 2011–2019 · strength 0.57
  5. Elisa Giovannetti · 6 shared papers, 2014–2019 · strength 0.36
  6. Tamara Gall · 6 shared papers, 2013–2015 · strength 0.26
  7. Niccola Funel · 3 shared papers, 2015–2019 · strength 0.18
  8. Sladjana Zagorac · 2 shared papers, 2018–2019 · strength 0.14
  9. Sara Maria David Trabulo · 2 shared papers, 2018–2019 · strength 0.14
  10. Silvia Ottaviani · 2 shared papers, 2018–2019 · strength 0.14
  11. Christopher Heeschen · 2 shared papers, 2018–2019 · strength 0.14
  12. Thomas Mathias Gress · 2 shared papers, 2018–2019 · strength 0.14
  13. Nagy Adley Habib · 2 shared papers, 2015–2018 · strength 0.12
  14. Edward L. S. Leen · 1 shared paper, 2018 · strength 0.10
  15. Harpreet Singh Wasan · 1 shared paper, 2018 · strength 0.10
  16. Nigel Balfour Jamieson · 2 shared papers, 2014–2015 · strength 0.09
  17. Zaynab Jawad · 1 shared paper, 2018 · strength 0.07
  18. Laura L. Meijer · 1 shared paper, 2015 · strength 0.06
  19. Tessa Y. S. Le Large · 1 shared paper, 2015 · strength 0.06
  20. Geert Kazemier M · 1 shared paper, 2015 · strength 0.06
  21. Andrés Jesús Muñoz Martín · 1 shared paper, 2016 · strength 0.04
  22. Satvinder Mudan · 1 shared paper, 2016 · strength 0.04
  23. Demetris Papamichael · 1 shared paper, 2016 · strength 0.04
  24. Douglas J.A. Adamson · 1 shared paper, 2016 · strength 0.04
  25. Ray McDermott · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.